Cera, the UK’s largest HealthTech company, has secured $150 million (£122 million) in funding to further develop its AI-powered home healthcare solutions. The milestone funding round was led by Schroders Capital and BDT & MSD Partners. This funding round highlights Cera’s mission to reduce pressure on the NHS, improve patient care, and address critical challenges in the healthcare sector.
AI at the Core of Transforming Healthcare:
Cera’s groundbreaking model uses AI to provide preventive, in-home care, responding to issues of over-stretched emergency services, a rapidly ageing population, and long hospital waiting lists. The data-driven approach that the company follows has delivered phenomenal results:
- 20% reduction in patient falls.
- Up to 70% decrease in emergency hospital admissions.
- AI is making faster hospital discharge processes possible, where patients can go home sooner and be properly cared for.
Cera is redefining healthcare, providing a scalable solution to some of the UK’s most pressing health challenges.
Addressing the Healthcare Workforce Crisis:
In addition to patient outcomes, Cera is dedicated to solving the staffing shortages that have long plagued the healthcare sector. The company received one million applications for nurse and carer roles over the past two years, demonstrating its ability to attract talent and meet growing workforce demands.
Cera’s technology also optimizes operational efficiency by streamlining travel routes and administrative tasks for carers. This innovation allows healthcare providers to dedicate an additional two hours of daily patient care per carer, enhancing the overall quality of service.
How the $150M Funding Will Be Used?
Cera intends to use the new funding to:
- Improve AI capabilities: Invest in next-generation AI technologies for better predictive care and decision-making.
- Expand specialized care services: Specialize in complex conditions and offer differentiated solutions.
- Conduct clinical trials: Validate new methods and models of care delivery to support innovation.
- Upskilling healthcare workers: Provide nurses and carers with similar training in AI tools so that technology is integrated seamlessly with hands-on care.
Investor Confidence and Proven Growth:
Cera’s remarkable achievements and potential for growth have inspired confidence among investors. In five years, it has exhibited a 150% compound annual growth rate. And it’s already cash-flow positive, the mark of efficiency in the business model.
Vahit Alili of Schroders Capital said the iron triangle of health care—quality, accessibility, and cost-effectiveness—is indeed being delivered in Cera’s business model.
Future of AI-Led Healthcare:
With this funding, Cera is well placed to further extend its leadership in HealthTech in the way care is delivered at home. By scaling its AI capabilities and its workforce, Cera is transforming healthcare delivery not only in the UK but also around the world, setting a global benchmark for AI-driven, patient-centric solutions.
